Judge’s ruling keeps $1 billion Carlton Energy Group lawsuit from forced arbitration

Posted on Friday, September 19th, 2014 at 9:53 am    

Several attorneys from Williams Kherkher are part of a team representing Carlton Energy Group LLC as they pursue $1 billion in unpaid African oil field profits.

Carlton Energy Group LLC claims the right to 10 percent of the profits earned for its stakes in a Cliveden Petroleum Co. LTD venture that began in 2000. Cliveden’s exploratory probe into the oil and gas resources of the Republic of Chad yielded highly profitable and unexpected results.

Some reports state that, upon finding out the field was worth billions, China National Petroleum Corp. (CNPC) moved to buy out Cliveden and dissolve all former partnerships. As a result, Carlton has yet to be paid.

After the initial suit against Cliveden was moved to federal court, Carlton successfully petitioned to add CNPC and other affiliated companies to the list of defendants named in the lawsuit. Cliveden petitioned to move quickly into arbitration, but a Texas Federal Judge recently ruled on the side of the plaintiff and agreed that “there is sufficient proof that [these newly named companies] should be added to the list of defendants” and as such, “the court cannot force arbitration.”

 


UK calls for fair treatment of BP in appeals court

Posted on Wednesday, September 17th, 2014 at 10:47 am    

The government of the United Kingdom suggested to the United States Supreme Court that it review appeals court rulings against London-based oil magnate BP Plc over the 2010 Gulf of Mexico oil spill fiasco that resulted in one of the most massive class action cases in America, Reuters reported on September 7.

The British government stated that the manner in which BP is being treated by the American courts is undermining the trust necessary for healthy and fruitful international commerce.

BP’s offshore oil rig Deepwater Horizon, which is located off the coast of Louisiana, exploded on April 20, 2010, causing oil to spew into the Gulf of Mexico. The company, now supported by the U.K., believes that compensation is now unfairly extending to parties who were not affected by this incident.

If you live near the Gulf area and your business and way of life has been affected by the massive 2010 Gulf of Mexico oil spill, you have the right to be compensated for your troubles. Turn to the attorneys at Williams Khekher by dialing (800) 220-9341 to acquire legal assistance today.


Risperdal and the risk of pancreatitis

Posted on Tuesday, September 16th, 2014 at 11:39 am    

Although Risperdal has been approved to treat symptoms of autism, bipolar disorder, and schizophrenia, several clinical studies have suggested the drug may cause severe side-effects. In fact, a 2003 article published in Pharmacotherapy noted an increased incidence of pancreatitis among various atypical antipsychotics, including Risperdal.

Pancreatitis, or the inflammation of the pancreas, occurs when digestive enzymes are activated in the pancreas instead of the small intestine. Characteristic symptoms are abdominal pain that may radiate to the back, nausea and vomiting. Due to its many life-threatening complications, such as kidney failure, severe lung dysfunction, dehydration, and shock, pancreatitis is regarded a medical emergency that requires immediate hospitalization and monitored care.

Our dedicated team of pharmaceutical defect attorneys at Williams Kherkher have been helping Risperdal victims file claims against the drug manufacturer if they suffer from complications caused by this potentially harmful medication. To see if we can put our experience to work for you, call our offices at (800) 220-9341 today.


New hip replacement surgery methods

Posted on Friday, September 12th, 2014 at 9:12 am    

According to Dr. Jordan Schaeffer of the Salt Lake Regional Medical Center in Salt Lake City, Utah, people who are worried about undergoing potentially majorly invasive hip implant operations can opt for less muscle-intensive procedures, Good4Utah reported on August 12.

Schaeffer noted that while traditional hip implant surgeries are generally successful and bring about medically fulfilling results for the hip implant patient, newer techniques involving muscle- and tissue-sparing approaches are also very promising.

An example of this procedure is the anterior hip replacement surgery. This is usually performed by cutting an incision on the patient’s side or back. This is done to avoid involving the major muscle groups and only involves the joint of the muscles.

Although hip implant methods are constantly evolving, the attorneys at Williams Kherkher know that many patients have suffered dangerous side effects from DePuy hip implants in particular. If you or a loved one has experienced this, call our Houston offices at 800-220-9341 today.


Detroit Lions’ Kyle Van Noy may have sports hernia

Posted on Thursday, September 11th, 2014 at 12:38 pm    

The Detroit Lions are in danger of opening the season without their rookie linebacker Kyle Van Noy due to severe abdominal pain that has yet to be diagnosed.

Van Noy said he fears that his latest injury could be a sports hernia, a condition that can take him out of the game for four to six weeks. He cannot determine the exact incident that caused the injury, but his condition has recently worsened, until he finally had to be benched during practices on Thursday, August 21.

Coach Jim Caldwell did not comment on questions regarding the possibility that this may be a long-term injury, thus affecting his status in the team.

Tahir Whitehead started the season as strong-side linebacker, bypassing Ashlee Palmer and the injured Van Noy.

Your doctor may recommend different courses of treatment for a hernia depending on your individual situation and the severity of the condition. However, be aware that the AlloDerm hernia patch has been associated with negative side effects, such as a recurrence, infection, and rejection. Contact our attorneys of Williams Kherkher today at (800) 220-9341 to pursue legal action if you have had the same issues with your AlloDerm use.


The difference between hemodialysis and peritoneal dialysis

Posted on Wednesday, September 10th, 2014 at 11:29 am    

Dialysis is defined as the process of taking away waste products and excess water from the body. This is often a necessary procedure for those suffering from chronic kidney disease or related problems.

Hemodialysis is the process of removing electrolytes, waste products, and fluids from the body through the circulatory system, meaning that blood is pumped from the artery into the dialysis machine and back.

On the other hand, peritoneal dialysis is the removal of electrolytes, waste products, and fluids from the body using the peritoneum – the membrane that forms the lining of the abdominal cavity – as a diffusing membrane. A solution called a dialysate (which contains water, glucose, and normal serum electrolytes) would be inserted into the peritoneal cavity using a catheter.

Some dialysis treatments involve the use of dialysate GranuFlo, which unfortunately may result in serious side effects, such as low blood pressure or sudden death. If you or a loved one has suffered as the result of GranuFlo, the attorneys at Williams Kherkher may help you pursue negligent drug manufacturers for financial compensation. Call our offices today at 800-220-9341 to learn more.


FDA approve drug to treat blood clots

Posted on Wednesday, September 10th, 2014 at 9:52 am    

A drug was recently approved by the US Food and Drug Administration (FDA) to treat blood clots, an article of Uncover California stated on August 22.

Reports said anticoagulant drug Eliquis (apixaban) was approved by the FDA to treat pulmonary embolism (PE) and deep vein thrombosis (DVT) with can result in a number of serious conditions such as heart attack, stroke, and pulmonary embolism. However, there are risks associated with taking and discontinuing the drug, so be sure to consult a medical professional to see if you are a good candidate for this treatment. Eliquis’ approval was made public by Bristol-Myers Squibb and Pfizer Inc.

Unfortunately many women suffer from deep vein thrombosis and pulmonary embolism as a result of taking Yasmin or Yaz contraceptives. If you develop either of these conditions, it is important to get a lawyer’s help in order to fund your treatment. Find out how the lawyers of Williams Kherkher may possibly help you recover your losses today by calling (800) 220-9341.


No elevated risk of complications from VT treatment in children with cleft

Posted on Wednesday, September 10th, 2014 at 9:19 am    

A recent study in Scotland suggests that complications from ventilation tube (VT) treatment in children with cleft lip and palate (CLP) are not any more common than other populations, MedicalXpress reported on August 28.

Researchers at Royal Hospital for Sick Children in Glasgow used VT to treat for chronic ear infections and related problems in 60 children with clefts and compared the rate of complications with a control group. The researchers found that only an average of 2.4 percent of children with clefts had complications with VT, while those without clefts had a 3.2 percent rate of complication. Since chronic ear infections are so common in a population already vulnerable to speech and developmental delays, some specialists, like Sr. Ian Smillie, M.R.C.S. Ed., are recommending VT sooner and in more cases.

Dealing with chronic ear infections are only one obstacle arising from cleft lip and palate. Although the cause of CLP is unknown, there is a higher risk of this condition when the baby was exposed to Topamax in utero. If you think your loved one developed CLP due to Topamax use, the lawyers of Williams Kherkher may work for you. Find out how we may possibly help you recover your losses today by calling (800) 220-9341.


DePuy pinnacle hip trial underway in Dallas

Posted on Tuesday, September 9th, 2014 at 5:45 pm    

A national court case against New Jersey-based Johnson & Johnson’s DePuy, a hip implant manufacturer, began on Wednesday, September 3 in Dallas, Texas and is being heard by U.S. District Judge Ed Kinkeade.

Montana resident and plaintiff Kathleen Herlihy-Paoli is suing DePuy for its DePuy pinnacle hip, which the company stopped selling in August 2013. Herlihy-Paoli and her attorneys are claiming that the DePuy pinnacle hip was not subjected to full product testing before being marketed to orthopedic surgeons and finally being sold to consumers in the market.

Paoli told the court that she had the implant attached to her body in 2009, and now has a total of five implants in both hips. She said that the metal-on-metal material on her implants caused her to feel negative side effects.

If you have been hurt due to using a defective DePuy hip implant, you have the right to press charges against the product’s manufacturers. To explore your legal options, talk with the attorneys at the Williams Kherkher Law Group by dialing (800) 220-9341 today.


GranuFlo, NaturaLyte trial in Massachusetts to start within the next few months

Posted on Monday, September 8th, 2014 at 5:54 pm    

Two years have passed since lawsuits have been filed against German dialysis product manufacturer Fresenius Medical Group due to its supposedly defective products, GranuFlo and NaturaLyte, but a pending suit is about to begin with a force. Plaintiffs and their attorneys are claiming that the manufacturers did not reveal the dangers that the acid concentrates inside their products hold for dialysis patients.

The bulk of these cases will be heard by federal and state courts in Massachusetts and Missouri, and in the coming months the courts will begin the task of selecting cases to be tried before juries in those states.

For example, if a person residing in California or Nebraska is suffering from an injury due to a defective GranuFlo product and files a lawsuit against its manufacturer in a federal court in those states, their cases will be referred to the federal court in Massachusetts or Missouri for handling of discovery and other pre-trial preparations.

The process of dialysis has been helping chronic kidney patients cope with their illness for years. Unfortunately, some dialysis products, including GranuFlo, have been linked to a multitude of negative side effects like cardio arrest. If you have experienced suffering from negative effects of GranuFlo, contact our attorneys at the Williams Kherkher Law Group by dialing 800-220-9341 today so we can provide you with legal assistance.


1 2 3 25

Williams Kherkher | 8441 Gulf Fwy #600 | Houston, TX 77017 | Phone: (713) 230-2200 | Toll Free: (800) 220-9341 | Directions